NeoGenomics
NEO
119 hedge funds and large institutions have $434M invested in NeoGenomics in 2015 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 10 closing their positions.
478% more call options, than puts
Call options by funds: $1.06M | Put options by funds: $183K
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
98% more capital invested
Capital invested by funds: $220M → $434M (+$215M)
19% more funds holding
Funds holding: 100 → 119 (+19)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
Top Buyers
| 1 |
GE
General Electric
Evendale,
Ohio
|
+$110M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.75M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
+$4.2M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$3.35M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.93M |
Top Sellers
| 1 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$6.05M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$4.39M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$3.59M |
| 4 |
Morgan Stanley
New York
|
-$2.32M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
-$1.13M |
NEO Hedge Fund Activity: Q4 2015 in Review
119 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2015, worth a combined $434M — up 98% from $220M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new NEO positions and 10 closed out — a net gain of 19 holders — while 34 added to existing stakes and 32 trimmed.
The largest buyer was General Electric, opening a new position worth an estimated $110M. The largest seller was Curi RMB Capital, cutting an estimated $6.05M.
- 119 institutional investors held NeoGenomics (NEO) as of Q4 2015, up from 100 in Q3 2015.
- Funds reported $434M of NeoGenomics stock for Q4 2015, up 98% quarter-over-quarter.
- 29 funds opened new NeoGenomics positions in Q4 2015 and 10 closed out, a net change of +19 holders.
- The largest NeoGenomics buyer in Q4 2015 was General Electric, an estimated $110M added.
- The largest NeoGenomics seller in Q4 2015 was Curi RMB Capital, an estimated $6.05M sold.
Based on aggregated 13F filings for Q4 2015.